Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S H Cheng

Showing results (241-250 of 255) with videos related to

Pageof 26
Sort By:
Human Gene Therapy|September 10, 1996
Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lungE R Lee, J Marshall, C S Siegel, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 17, 2019
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetesGaurav S Gulsin, Prathap Kanagala, Daniel C S Chan, et al.
Journal of Viral Hepatitis|October 13, 2009
Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunityH-Y Sun, H-C Lee, C-E Liu, et al.
Gene Therapy|November 8, 2013
Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lungE W F W Alton, A C Boyd, S H Cheng, et al.
Gene Therapy|October 3, 2007
Progress and prospects: gene therapy clinical trials (part 1)B L Alexander, R R Ali, E W F Alton, et al.
Lancet (London, England)|August 25, 1999
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trialE W Alton, M Stern, R Farley, et al.
Human Gene Therapy|May 8, 2001
A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosisF E Ruiz, J P Clancy, M A Perricone, et al.
Oncogene|November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathV W Y Lui, E Y L Wong, K Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasmaD C T Chan, W K J Lam, E P Hui, et al.
American Journal of Human Genetics|October 6, 2020
Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo CorrectionRebecca W Y Chan, Lee Serpas, Meng Ni, et al.
Pageof 26

Showing results (241-250 of 255) with videos related to

Sort By:
Pageof 26
Human Gene Therapy|September 10, 1996
Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lungE R Lee, J Marshall, C S Siegel, et al.
Therapeutic Advances in Endocrinology and Metabolism|July 17, 2019
Differential left ventricular and left atrial remodelling in heart failure with preserved ejection fraction patients with and without diabetesGaurav S Gulsin, Prathap Kanagala, Daniel C S Chan, et al.
Journal of Viral Hepatitis|October 13, 2009
Factors associated with isolated anti-hepatitis B core antibody in HIV-positive patients: impact of compromised immunityH-Y Sun, H-C Lee, C-E Liu, et al.
Gene Therapy|November 8, 2013
Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lungE W F W Alton, A C Boyd, S H Cheng, et al.
Gene Therapy|October 3, 2007
Progress and prospects: gene therapy clinical trials (part 1)B L Alexander, R R Ali, E W F Alton, et al.
Lancet (London, England)|August 25, 1999
Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: a double-blind placebo-controlled trialE W Alton, M Stern, R Farley, et al.
Human Gene Therapy|May 8, 2001
A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosisF E Ruiz, J P Clancy, M A Perricone, et al.
Oncogene|November 9, 2010
Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell deathV W Y Lui, E Y L Wong, K Ho, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 1, 2022
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein-Barr virus DNA in post-treatment plasmaD C T Chan, W K J Lam, E P Hui, et al.
American Journal of Human Genetics|October 6, 2020
Plasma DNA Profile Associated with DNASE1L3 Gene Mutations: Clinical Observations, Relationships to Nuclease Substrate Preference, and In Vivo CorrectionRebecca W Y Chan, Lee Serpas, Meng Ni, et al.
Pageof 26